ArticleAnnals of the rheumatic diseases2022

Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON.

Yannick Allanore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.